-
Continuing the ConversationThe AACR hosts a roundtable to ‘get real’ about cancer health disparities.
by Marci A. Landsmann
-
To Understand Disparities, Look at the Broader ContextsResearchers at the AACR Annual Meeting 2024 consider ways in which social and economic factors like location affect cancer risk and outcomes.
by Eric Fitzsimmons
-
Overcoming Lung Cancer Stigma With UnderstandingShirley Muñoz wants to use her experience as a younger lung cancer patient to break down barriers to care for her community through translation and advocacy.
by Cameron Walker
-
Women Less Satisfied With Cancer CareCompared with men, women’s initial cancer symptoms are less likely to be taken seriously.
by Sandra Gordon
-
Thinking Outside the ClinicResearchers highlight need for outreach and educational programs to address survivorship disparities.
by Thomas Celona
-
Cultural Competence in the CommunityResearchers describe their efforts to understand and improve cancer screening and treatment among underserved populations.
by Kevin McLaughlin
-
Working Toward the End of Cancer Health DisparitiesAACR conference explores the science of cancer disparities and what needs to be done to improve cancer outcomes for all people.
by Eric Fitzsimmons
-
Risk in the AirAir pollution can increase a person's risk of developing cancer, a burden that isn't shared equally in every neighborhood.
by Jon Kelvey
-
The Individual Sphere of InfluenceCan discussion of health inequities lead to actionable change?
by Marci A. Landsmann
-
Building COVID-19 Vaccine ConfidenceExperts discussed how the cancer community can share accurate information and increase confidence in COVID-19 vaccines, both among people with cancer and the general population.
by Kevin McLaughlin
New research indicates that adding immunotherapy to muscle-invasive bladder cancer treatment can improve event-free and overall survival.
by Laura Gesualdi-Gilmore
Cancer Patients Who Quit Smoking, Even Years After Diagnosis, Live LongerFindings from a recent study support smoking cessation after diagnosis, with the most pronounced effect in those who received treatment within six months of diagnosis.
by Kyle Bagenstose
Delaying Treatment ResistanceAdding a CDK 4/6 inhibitor extends progression-free survival for people with metastatic HR-positive, HER2-positive breast cancer.
by Thomas Celona
2024: The Year in Cancer NewsThe Cancer Today editors share the most impactful reporting on cancer research from 2024.
by Cancer Today staff
-
AACR Grant Propels Progress in Immunotherapy ResearchA grant from the American Association for Cancer Research (AACR) helped Marco Ruella, MD, develop a new approach to immunotherapy.
-
Self-screening for Cancer: Home Sweet HomeNew cervical cancer self-screening options and a portable blood test device could lead to changes in at-home cancer screening.
Dr. Humberto M. Guiot: Targeting Pancreatic Cancer in a Community-Based Clinical Trial
